Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tharimmune, Inc. - Common Stock
(NQ:
THAR
)
4.740
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tharimmune, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Tharimmune Announces Positive FDA Feedback on NDA Path for TH104 for Prophylaxis of Respiratory and/or CNS Depression for Ultrapotent Opioid Exposure
March 31, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
March 24, 2025
Via
Benzinga
Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha
March 24, 2025
Via
ACCESS Newswire
Tharimmune Announces Positive Target Engagement with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick Technology
March 04, 2025
Via
ACCESS Newswire
THAR Stock Earnings: Tharimmune Reported Results for Q2 2024
↗
August 12, 2024
Tharimmune just reported results for the second quarter of 2024.
Via
InvestorPlace
Tharimmune to Present at the Microcap Conference 2025
January 27, 2025
Via
ACCESS Newswire
Tharimmune Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis and Provides a Business Update
December 16, 2024
Via
ACCESSWIRE
Tharimmune Announces $2.02 Million Private Placement to Advance Development Programs
December 06, 2024
Via
ACCESSWIRE
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
November 27, 2024
Via
ACCESSWIRE
What's Going On With Tharimmune Shares Monday?
↗
November 18, 2024
Tharimmune, Inc. (NASDAQ:THAR) shares initially traded higher on Monday, but have since reversed after the company presented clinical data at the 75th American Association for the Study of Liver...
Via
Benzinga
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
November 18, 2024
Via
ACCESSWIRE
Tharimmune Granted European Patent for Delivery of Optimized Molecularly Targeted Therapeutics
November 13, 2024
Via
ACCESSWIRE
10 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 04, 2024
Via
Benzinga
Tharimmune Announces Upcoming Conference Presentations
November 04, 2024
Via
ACCESSWIRE
Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast
↗
October 30, 2024
Via
Benzinga
S&P 500 Edges Lower; US Crude Oil Inventories Fall
↗
October 30, 2024
Via
Benzinga
Topics
Stocks
What's Going On With Tharimmune Shares Wednesday?
↗
October 30, 2024
Tharimmune, Inc. (NASDAQ:THAR) shares are moving higher on Wednesday after the company announced it received overall positive feedback from the European Medicines Agency (EMA) on its TH104 clinical...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 30, 2024
Via
Benzinga
Dow Surges Over 150 Points; Alphabet Posts Upbeat Results
↗
October 30, 2024
Via
Benzinga
Topics
Stocks
Tharimmune Receives Positive Regulatory Feedback From EMA for TH104 Clinical Program for Chronic Pruritus in Primary Biliary Cholangitis
October 30, 2024
Via
ACCESSWIRE
Tharimmune Announces Upcoming Conference Presentations
October 25, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
September 30, 2024
Via
Benzinga
Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma to Create Transformative Oral Biologic Therapeutics Company
September 30, 2024
Via
ACCESSWIRE
Tharimmune Acquires Global License and Partners With Intract Pharma to Develop an Oral Formulation of Infliximab
September 16, 2024
Via
ACCESSWIRE
Tharimmune Appoints Prof. David Jones of Newcastle University to its Scientific Advisory Board
July 22, 2024
Via
ACCESSWIRE
Tharimmune Appoints Global Business Executive David H. Clarke as Key Strategic Advisor
July 17, 2024
Via
ACCESSWIRE
Tharimmune Launches New Website as Discussions with FDA Continue for Phase 2 Clinical Trial with TH104
July 16, 2024
Via
ACCESSWIRE
Tharimmune Appoints Jules Haimovitz as Key Strategic Advisor
July 10, 2024
Via
ACCESSWIRE
Tharimmune Announces $2.08 Million Private Placement
June 20, 2024
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
